Session Title:
Novel Blood based biomarkers in the assessment of Traumatic Brain Injury
Synopsis:
As international clinical bodies and societies across America and Europe begin inclusion of blood-based biomarkers to aid in the assessment of mild traumatic brain injury, how do we look to bring this to ANZ ED Departments.
In this Breakfast symposium Abbott invites you to hear firsthand from Dr Martina Pavletic about the experience of implementing the biomarkers in her Emergency Department in Croatia, including improvements of patient flow and reduction in CT scans. From there, Dr Moodley will outline the greater global landscape and the ANZ contribution.
Presentation 1:
Strategy for introducing blood-based biomarkers for mild TBI in the Emergency Department by Dr. Martina Pavletic
Presentation 2:
International clinical adoption of the Abbott mTBI Biomarkers by Dr. Terence Moodley